Avitar, Inc. and Sun Biomedical Laboratories complete first phase of saliva-based drugs of abuse tests.CANTON Canton, cities, United States Canton. 1 City (1990 pop. 13,922), Fulton co., W central Ill., in the corn belt; inc. 1849. It is a trade and industrial center for a coal and farm area. 2 Town (1990 pop. 18,530), Norfolk co. , MA--(BUSINESS WIRE)--February 27, 1997--Avitar, Inc. ("the Company") (Nasdaq SmallCap Market:AVIT AVIT Aarupadai Veedu Institute of Technology AVIT Audiovisual Instructional Technology (Common Stock); AVITW (Redeemable Warrants)) today announced the successful completion of the first phase of its development of saliva-based drugs of abuse tests in its joint program with Sun Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Laboratories. These tests incorporate Avitar's patent-pending saliva saliva Thick, colourless fluid constantly present in the mouth, composed of water, mucus, proteins, mineral salts, and amylase, an enzyme that breaks down starches. One to two litres are produced daily by the salivary glands. collection system. The first phase has included studies of the suitability of saliva as a sample for existing urine based drugs of abuse tests and modification of the tests system to effectively use this more easily collected, but challenging test medium. Dr. Carl Good, Vice President - Research & Development of Avitar, stated, "Innovative techniques were developed to provide a simple, easy-to-use method of performing the rapid screening tests using saliva. The Company plans to conduct clinical trials later this spring at a major university. The marketplace has indicated a significant preference for a saliva-based rather than urine-based test system, since a saliva sample provides for a clear chain of custody The movement and location of physical evidence from the time it is obtained until the time it is presented in court. Judges in bench trials and jurors in jury trials are obligated to decide cases on the evidence that is presented to them in court. without the current embarrassing process of certifying the origin of a urine sample." The Company designs, develops, manufactures and markets healthcare products and services including Hydrasorb(TM), a proprietary line of polyurethane polyurethane Any of a class of very versatile polymers that are made into flexible and rigid foams, fibres, elastomers (elastic polymers), surface coatings, and adhesives. wound care dressings. The Company also provides healthcare cost containment cost containment, n the features of a dental benefits program or of the administration of the program designed to reduce or eliminate certain charges to the plan. services to employers and third-party payors. This press release contains forward looking statements which involve numerous risks and uncertainties. The Company's actual results could differ materially from those anticipated in such forward looking statements as a result of certain factors, including those set forth in the Company's filings with the Securities and Exchange Commission. CONTACT: AVITAR, INC. Peter Phildius, Chairman of the Board (617) 575-9790 or Jay Leatherman, Chief Financial Officer (203) 265-3594 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion